MetaCap

Supernus Statistics

NASDAQ: SUPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

28.61+0.26 (+0.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Supernus by the numbers

Supernus has a market capitalization of $5.94 billion based on 207.72M shares outstanding. With trailing EPS of $-0.76, Supernus is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.2% below its 50-day average and 18.9% below its 200-day average.

Average daily trading volume is 2.77M shares, or about $79.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SUPN valuation vs. peer median

SUPN compared with the median of 8 peer companies
MetricSUPNPeer medianDifference
Market cap$5.94B$5.79B+3%
Forward P/E7.129.7-76%
Avg. volume2.77M715.37K+287%

Peer median across 8 companies: ARWR, LGND, GRFS, MIRM, ABVX, BLTE, MANE, AXSM.

Valuation

Price / sales (latest FY)
8.27
EPS (TTM)
$-0.76

Price and trading

Previous close
28.35
Open
28.39
Day range
28.15 – 29.51
52-week range
25.92 – 42.81
52-week change
-36.87%
Beta
—
Volume
2.83M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
5.94B
Forward Pe
7.15
Eps
-0.76
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
42.81
Week52 Low
25.92
Avg Volume
2.77M
Shares Outstanding
207.72M
Ma50
33.33
Ma200
35.28
Earnings Date
Oct 29, 2026
Pct From52w High
-33.17%
Pct From52w Low
10.38%

Related